Free Trial
ASX:DTR

Dateline Resources (DTR) Stock Price, News & Analysis

Dateline Resources logo

About Dateline Resources Stock (ASX:DTR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
18.03 million shs
Average Volume
N/A
Market Capitalization
A$10.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dateline Resources and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DTR Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
See More Headlines

DTR Stock Analysis - Frequently Asked Questions

Dateline Resources Limited (ASX:DTR) issued its earnings results on Friday, March, 16th. The company reported $0.00 earnings per share (EPS) for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dateline Resources investors own include Bam Bam Resources (NPEZF), E3 Metals (ETMC), Blackstone Minerals (BSX), Zogenix (ZGNX), Vesuvius (VSVS), PreveCeutical Medical (PRVCF).

Company Calendar

Last Earnings
3/16/2018
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
N/A
Current Symbol
ASX:DTR
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$17.24 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-359.28%
Return on Assets
-17.93%

Debt

Debt-to-Equity Ratio
154.91
Current Ratio
0.44
Quick Ratio
0.12

Sales & Book Value

Annual Sales
A$169.69 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,520,000,000
Free Float
N/A
Market Cap
A$10.07 million
Optionable
Not Optionable
Beta
-0.10
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:DTR) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners